319 related articles for article (PubMed ID: 17937567)
1. Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials.
Arnold LM; Pritchett YL; D'Souza DN; Kajdasz DK; Iyengar S; Wernicke JF
J Womens Health (Larchmt); 2007 Oct; 16(8):1145-56. PubMed ID: 17937567
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study.
Arnold LM; Zhang S; Pangallo BA
Clin J Pain; 2012; 28(9):775-81. PubMed ID: 22971669
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder.
Arnold LM; Rosen A; Pritchett YL; D'Souza DN; Goldstein DJ; Iyengar S; Wernicke JF
Pain; 2005 Dec; 119(1-3):5-15. PubMed ID: 16298061
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
Upadhyaya HP; Arnold LM; Alaka K; Qiao M; Williams D; Mehta R
Pediatr Rheumatol Online J; 2019 May; 17(1):27. PubMed ID: 31138224
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial.
Russell JI; Mease PJ; Smith TR; Kajdasz DK; Wohlreich MM; Detke MJ; Walker DJ; Chappell AS; Arnold LM
Pain; 2008 Jun; 136(3):432-444. PubMed ID: 18395345
[TBL] [Abstract][Full Text] [Related]
7. Flexible dosed duloxetine in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial.
Arnold LM; Clauw D; Wang F; Ahl J; Gaynor PJ; Wohlreich MM
J Rheumatol; 2010 Dec; 37(12):2578-86. PubMed ID: 20843911
[TBL] [Abstract][Full Text] [Related]
8. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients.
Murakami M; Osada K; Mizuno H; Ochiai T; Alev L; Nishioka K
Arthritis Res Ther; 2015 Aug; 17(1):224. PubMed ID: 26296539
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
Arnold LM; Hudson JI; Wang F; Wohlreich MM; Prakash A; Kajdasz DK; Chappell AS
Clin J Pain; 2009; 25(6):461-8. PubMed ID: 19542792
[TBL] [Abstract][Full Text] [Related]
11. Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial.
Arnold LM; Wang F; Ahl J; Gaynor PJ; Wohlreich MM
Arthritis Res Ther; 2011 Jun; 13(3):R86. PubMed ID: 21668963
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.
Bennett R; Russell IJ; Choy E; Spaeth M; Mease P; Kajdasz D; Walker D; Wang F; Chappell A
Clin Ther; 2012 Apr; 34(4):824-37. PubMed ID: 22421576
[TBL] [Abstract][Full Text] [Related]
13. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.
Mease PJ; Russell IJ; Kajdasz DK; Wiltse CG; Detke MJ; Wohlreich MM; Walker DJ; Chappell AS
Semin Arthritis Rheum; 2010 Jun; 39(6):454-64. PubMed ID: 19152958
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.
Brecht S; Courtecuisse C; Debieuvre C; Croenlein J; Desaiah D; Raskin J; Petit C; Demyttenaere K
J Clin Psychiatry; 2007 Nov; 68(11):1707-16. PubMed ID: 18052564
[TBL] [Abstract][Full Text] [Related]
15. Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain.
Konno S; Oda N; Ochiai T; Alev L
Spine (Phila Pa 1976); 2016 Nov; 41(22):1709-1717. PubMed ID: 27831985
[TBL] [Abstract][Full Text] [Related]
16. Duloxetine for fibromyalgia syndrome: a systematic review and meta-analysis.
Migliorini F; Maffulli N; Eschweiler J; Baroncini A; Bell A; Colarossi G
J Orthop Surg Res; 2023 Jul; 18(1):504. PubMed ID: 37461044
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of esreboxetine in patients with fibromyalgia: a fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial.
Arnold LM; Hirsch I; Sanders P; Ellis A; Hughes B
Arthritis Rheum; 2012 Jul; 64(7):2387-97. PubMed ID: 22275142
[TBL] [Abstract][Full Text] [Related]
18. A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms.
Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Marangell LB
Curr Med Res Opin; 2011 Oct; 27(10):1849-58. PubMed ID: 21838411
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of duloxetine in patients with fibromyalgia: pooled analysis of 4 placebo-controlled clinical trials.
Arnold LM; Clauw DJ; Wohlreich MM; Wang F; Ahl J; Gaynor PJ; Chappell AS
Prim Care Companion J Clin Psychiatry; 2009; 11(5):237-44. PubMed ID: 19956462
[TBL] [Abstract][Full Text] [Related]
20. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?
Fava M; Mallinckrodt CH; Detke MJ; Watkin JG; Wohlreich MM
J Clin Psychiatry; 2004 Apr; 65(4):521-30. PubMed ID: 15119915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
